跳至主要内容
临床试验/NCT02745470
NCT02745470已完成不适用

Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain Measured by Functional MRI

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Difference of BOLD (Blood oxygenation level-dependent) signal in hypothalamus

研究概览

简要总结

The aims this study is to explore the effect of a GLP-1 receptor agonist on the degree of brain activation and connectivity obtained by functional magnetic resonance imaging in lean and obese type 2 diabetes

详细描述

Fifteen lean [BMI(body mass index) less than 23 kg/m2] type 2 diabetes subjects and fifteen obese (BMI more than 26 kg/m2) subjects with type 2 diabetes treated by diet and/or metformin, SU(sulfonylurea), DPP4-inhibitors(Dipeptidyl peptidase-4 inhibitor) will be recruited. Every subject will be studied on 2 separate days in random order with 1-2 week intervals. These participants will be injected either normal saline or 10 mcg of lixisenatide in a cross-over fashion. Neuroimaging composed with resting-12-min, visual stimulation task-12-min, T1-5-min, and diffusion tensor image-12-min will be proceeded. Ad lib buffet will be provided to every participant and the intake will be measured. Surveys about appetite and mood will be done before and after neuroimaging test and buffet eating.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI ≤ 23kg/m2 or BMI ≥ 26kg/m2
  • participants with diabetes treated by diet or oral antidiabetic drug, HbA1c less than 8.5%

排除标准

  • Those who diagnosed by Type 1 diabetes
  • History of insulin therapy
  • Aspartate aminotransferase(AST) or Alanine transaminase(ALT) >2.5 times of upper normal reference range
  • Estimated Glomerular Filtration Rate(eGFR) <30 mL/min/1.73m2
  • Those who can't be performed MRI

研究组 & 干预措施

Lixisenatide injection

Experimental

intervention : Lyxumia® pen injection 10 microgram (Lixisenatide) subcutaneous injection 30 minutes before functional MRI

干预措施: Lixisenatide (Drug)

Normal saline

Placebo Comparator

control : normal saline 0.3 cc subcutaneous injection before functional MRI

干预措施: Placebo (Other)

结局指标

主要结局

Difference of BOLD (Blood oxygenation level-dependent) signal in hypothalamus

时间窗: 10min (40 min after injection)

Whole brain connectivity

时间窗: 20min (50 min after injection)

次要结局

  • intake of food in the buffet(50min)
  • mood change(-30min, 45min(after fMRI), 70min(after buffet))
  • appetite change(-30min, 45min(after fMRI), 70min(after buffet))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验